. Southern blot analysis of lung tissues after tamoxifen induction. To assess the efficiency of Cre-mediated deletion of the loxP-flanked Calpain-4 gene segment in ER-Cre +/-Capn4 flox/+ mice, Southern blot analysis was done with genomic DNA from lung tissues of control and knockout mice as described previously by us (Genesis. 2006; 44(6):297-303) . After PstI digestion, fragments corresponding to floxed CAPN4 PZ allele, and excised CAPN4 P genes were predicted at sizes of 3.2, and 4.3 kb, respectively. (A): Tamoxifen treatment caused the appearance of a 4.3-kb band and the weakening of the 3.2-kb band in the lungs of ER-Cre +/-Capn4 flox/+ mice. (B) is a bar graph depicting the changes in floxed CAPN4 PZ allele. Results are expressed as mean ± SE; n=6. * P < 0.05 vs. control mice. Supplemental Figure 4 . Effects of calpain inhibitor MDL28170 on SBDP and collagen-1 in the smooth muscle of pulmonary arterioles of rats with MCT-induced pulmonary hypertension. Male Sprague-Dawley rats with age of 8 weeks were injected subcutaneously without or with MCT (60 mg/kg). After 2 weeks, control rats and MCT-injected rats (MCT 2 weeks) were subjected to determination of pulmonary hypertension and pulmonary vascular remodeling. At same time (the beginning of third week), another groups of control rats (MDL 28170) and MCT-injected rats (MCT 3 weeks+MDL28170) started to receive calpain inhibitor MDL28170 (20 mg/kg, i.p.) once daily. A second group of MCT-injected rats received same volume of vehicle (MCT 3 weeks). Pulmonary hypertension and pulmonary vascular remodeling were accessed one week later (3 weeks after MCT injection). (A): Lung slides were double-stained for α-actin (red) and collagen-I (green). (B): Lung slides were double-stained for α-actin (red) and SBDP (green). Images are representative of 6 independent experiments. Magnification x400. 
Pulmonary vascular remodeling
Supplemental Figure 12 . A schematic pathway illustrating the role of calpain in pulmonary vascular remodeling of pulmonary hypertension. PDGF and EGF released in hypoxia-or MCT-induced pulmonary hypertension cause activation of calpain which translocates to Golgi and induces activation of TGFβ. TGFβ/p-Smad signaling leads to collagen synthesis and smooth muscle proliferation which contributes to pulmonary vascular remodeling and pulmonary hypertension.
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